Literature DB >> 9264484

Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability.

P R Pagley1, G A Beller, D D Watson, L W Gimple, M Ragosta.   

Abstract

BACKGROUND: Although residual myocardial viability in patients with coronary artery disease and extensive regional asynergy is associated with improved ventricular function after coronary bypass surgery, the relationship between viability and clinical outcome after surgery is unclear. We hypothesized that patients with poor ventricular function and predominantly viable myocardium have a better outcome after bypass surgery compared with those with less viability. METHODS AND
RESULTS: Seventy patients with multivessel coronary artery disease and left ventricular ejection fractions < 40% who underwent preoperative quantitative 201Tl scintigraphy before coronary bypass surgery were analyzed retrospectively. 201Tl scintigrams were reviewed blindly, and each segment was assigned a score based on defect magnitude. Segmental viability scores were summed and divided by the number of segments visualized to determine a viability index. The viability index was significantly related to 3-year survival free of cardiac event (cardiac death or heart transplant) after bypass surgery (P=.011) and was independent of age, ejection fraction, and number of diseased coronary vessels. Patients with greater viability (group 1; viability index > 0.67; n=33) were similar to patients with less viability (group 2; viability index < or = 0.67; n=37) with respect to age, comorbidities, and extent of coronary artery disease. There were 6 cardiac deaths and no heart transplants in group 1 patients and 15 cardiac deaths and two transplants in group 2 patients. Survival free of cardiac death or transplantation was significantly better in group 1 patients on Kaplan-Meier analysis (P=.018).
CONCLUSIONS: We conclude that resting 201Tl scintigraphy may be useful in preoperative risk stratification for identification of patients more likely to benefit from surgical revascularization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9264484     DOI: 10.1161/01.cir.96.3.793

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  66 in total

1.  The role of cardiac imaging in optimizing therapy in heart failure.

Authors:  A Lahiri
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

2.  Use of myocardial perfusion imaging to assess viability.

Authors:  M I Travin
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

Review 3.  Fluorine-18-deoxyglucose SPECT and coincidence imaging for myocardial viability: Clinical and technologic issues.

Authors:  V Dilsizian; S L Bacharach; M M Khin; M F Smith
Journal:  J Nucl Cardiol       Date:  2001 Jan-Feb       Impact factor: 5.952

4.  Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts.

Authors: 
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

Review 5.  Radionuclide techniques for the assessment of myocardial viability and hibernation.

Authors:  J J Bax; E E van der Wall; M Harbinson
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

Review 6.  Multimodality imaging for assessment of myocardial viability: nuclear, echocardiography, MR, and CT.

Authors:  James A Arrighi; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

7.  Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET.

Authors:  Riemer H J A Slart; Jeroen J Bax; Dirk J van Veldhuisen; Ernst E van der Wall; Rudi A Dierckx; Jaep de Boer; Pieter L Jager
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

Review 8.  Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery disease.

Authors:  N K Sabharwal; A Lahiri
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

9.  Combined assessment of left ventricular function and rest-redistribution regional myocardial thallium-201 activity for prognostic evaluation of patients with chronic coronary artery disease and left ventricular dysfunction.

Authors:  M Petretta; A Cuocolo; E Nicolai; W Acampa; M Salvatore; D Bonaduce
Journal:  J Nucl Cardiol       Date:  1998 Jul-Aug       Impact factor: 5.952

Review 10.  Role of Percutaneous Chronic Total Occlusion Interventions in Patients with Ischemic Cardiomyopathy and Reduced Left Ventricular Ejection Fraction.

Authors:  Nayef A Abouzaki; Jose E Exaire; Luis A Guzmán
Journal:  Curr Cardiol Rep       Date:  2018-10-01       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.